The University of Lübeck is a research university in Lübeck, Northern Germany which focuses almost entirely on medicine and sciences with applications in medicine.

During the past decade, University of Luebeck conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 3 clinical trials were completed, i.e. on average, 12% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 1 clinical trials were completed. i.e. 7.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Luebeck" #1 sponsor was "University of Luebeck" with 7 trials, followed by "University Hospital Schleswig-Holstein" with 4 trials sponsored, "Prof. Dr. med. Ingo Eitel" with 3 trials sponsored, "Charite University, Berlin, Germany" with 2 trials sponsored and "Drägerwerk AG & Co. KGaA" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Luebeck" #1 collaborator was "Charite University, Berlin, Germany" with 3 trials as a collaborator, "German Research Foundation" with 2 trials as a collaborator, "Zealand University Hospital" with 2 trials as a collaborator, "BARMER" with 1 trials as a collaborator and "Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)" with 1 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 24 trials.

According to Clinical.Site data, the most researched conditions in "University of Luebeck" are "Acute Myocardial Infarction" (2 trials), "Coronary Artery Disease" (2 trials), "Huntington's Disease" (2 trials), "Infertility" (2 trials) and "Spinal Cord Compression Due to Metastasis to Spine" (2 trials). Many other conditions were trialed in "University of Luebeck" in a lesser frequency.

Most popular intervention types in "University of Luebeck" are "Drug" (7 trials), "Other" (6 trials), "Device" (5 trials), "Behavioral" (3 trials) and "Diagnostic Test" (3 trials). Other intervention types were less common.

The name of intervention was led by "Prehabilitation- new form of care" (2 trials), "20 mg BID of PF-02545920" (1 trials), "Absorb GT1" (1 trials), "Blood samples and microbiological swaps" (1 trials) and "CoreValve Evolut R" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Luebeck" are 24 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are 13 active trials in "University of Luebeck". 1 are not yet recruiting, 10 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 6 completed trials in University of Luebeck, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in University of Luebeck, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 12 trials that are defined as “Not Applicable".

University of Luebeck has several departments that took part in Clinical trials: "Department of Radiation Oncology, University of Lübeck and University Medical Center Schleswig-Holstein" - 11 trials, "Department of Dermatology, University of Lübeck" - 2 trials, "University of Luebeck, Dept. of Neurology" - 2 trials